PHENYTEK Drug Patent Profile
✉ Email this page to a colleague
When do Phenytek patents expire, and what generic alternatives are available?
Phenytek is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in PHENYTEK is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phenytek
A generic version of PHENYTEK was approved as phenytoin sodium by WEST-WARD PHARMS INT on December 31st, 1969.
Summary for PHENYTEK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 151 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PHENYTEK |
| DailyMed Link: | PHENYTEK at DailyMed |
Pharmacology for PHENYTEK
Anatomical Therapeutic Chemical (ATC) Classes for PHENYTEK
US Patents and Regulatory Information for PHENYTEK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | PHENYTEK | phenytoin sodium | CAPSULE;ORAL | 040298-002 | Dec 6, 2001 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan | PHENYTEK | phenytoin sodium | CAPSULE;ORAL | 040298-003 | Dec 6, 2001 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
